Actinogen Medical (ACW) News Today → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free ACW Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEnrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trialfinance.yahoo.com - April 22 at 9:27 AMActinogen treats first subject in Alzheimer’s disease therapy trialmsn.com - April 16 at 4:10 PMActinogen Medical Limited: First patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trialfinanznachrichten.de - April 15 at 1:33 PMFirst patient treated in Actinogen's XanaMIA phase 2b Alzheimer's disease trialfinance.yahoo.com - April 15 at 1:33 PMInvestors in Actinogen Medical (ASX:ACW) have unfortunately lost 53% over the last yearfinance.yahoo.com - March 12 at 8:42 PMActinogen Medical delivers strong half-year results as it develops novel therapyproactiveinvestors.com.au - February 28 at 10:44 AMActinogen Medical on track to deliver two key Phase 2 trial results in next 18 monthsau.investing.com - February 27 at 11:34 PMDiagnosing mental disorder through sleep: How TrivarX could capture this huge research marketmsn.com - February 22 at 12:09 PMWill Actinogen Medical (ASX:ACW) Spend Its Cash Wisely?finance.yahoo.com - January 30 at 4:57 PMPositive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancyfinance.yahoo.com - January 24 at 8:40 AMActinogen Medical Ltd ACWmorningstar.com - December 13 at 10:21 AMActinogen XanaCIDD Phase 2a trial in patients with depression and cognitive impairment: enrolment accelerating and on track for results in second quarter of 2024finance.yahoo.com - November 28 at 10:30 AMShareholders May Be A Bit More Conservative With Actinogen Medical Limited's (ASX:ACW) CEO Compensation For Nowfinance.yahoo.com - November 10 at 5:57 PMActinogen to present progress on Phase 2 trials at the BIO Investor Forum, San Francisco and Clinical Trials on Alzheimer's Disease (CTAD) Conference, Bostonfinance.yahoo.com - October 13 at 9:37 AMActinogen optimizes XanaMIA Phase 2b Alzheimer's disease trial design and provides general business updatefinance.yahoo.com - September 26 at 1:21 PMActinogen to present progress on Cognitive Impairment in Depression and Alzheimer's Disease Phase 2 trials at the BIO International Conventionfinance.yahoo.com - May 31 at 12:34 PMThe 5 Best Travel Medical Insurance Plans for 2023travel.usnews.com - May 24 at 10:27 AMInvestors in Actinogen Medical (ASX:ACW) have made a strong return of 215% over the past three yearsuk.finance.yahoo.com - April 3 at 1:02 AMActinogen presents positive Phase 2a Xanamem data in at ADPD™ Alzheimer's and Parkinson's diseases conferencefinance.yahoo.com - March 30 at 11:36 AMActinogen Medical Limited (ATGGF)finance.yahoo.com - March 27 at 8:11 AMHere's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situationfinance.yahoo.com - January 12 at 12:48 AMFDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trialfinance.yahoo.com - December 22 at 7:57 AMActinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trialfinance.yahoo.com - December 14 at 2:55 PMActinogen Medical Ltdreuters.com - December 1 at 4:08 AMInvestors in Actinogen Medical (ASX:ACW) have made a splendid return of 212% over the past three yearsuk.finance.yahoo.com - October 25 at 11:59 AMActinogen Medical Stock (OTC:ATGGF), Earnings Estimates, EPS, and Revenuebenzinga.com - October 11 at 11:10 AMActinogen Medical share price crashes 67% lower on Alzheimer’s study resultsfool.com.au - October 10 at 2:17 PMActinogen Medical Limited (ACW) announces large Xanamem® therapeutic effect in early-stage Alzheimer's Disease (AD) patientsfinance.yahoo.com - October 10 at 9:16 AMGuess which ASX biotech share just rocketed 56% on new Alzheimer’s drug trial resultsfool.com.au - October 10 at 12:48 AMActinogen Medical Stock (OTC:ATGGF), Dividendsbenzinga.com - September 26 at 11:32 AMWe Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growthfinance.yahoo.com - August 4 at 7:21 PMActinogen Announces Phase 2 Trials in Alzheimer’s Disease and Depressionapnews.com - June 14 at 10:02 AMWe're Not Very Worried About Actinogen Medical's (ASX:ACW) Cash Burn Ratefinance.yahoo.com - February 25 at 10:52 PMActinogen Medical Limited (ACW.AX)finance.yahoo.com - February 12 at 10:48 PMASX Health Stocks: dorsaVi gets ISO certification; Actinogen to begin Phase 2 trialmsn.com - February 8 at 8:24 PMActinogen (ASX:ACW) share price surges 9% on Oxford Uni partnershipmsn.com - December 7 at 10:38 AMWhy the Actinogen (ASX:ACW) share price is sinking 16% on Tuesdaymsn.com - November 8 at 9:40 PMCheck Up: Paradigm targets Phase 3 clinical trial in the US; AI microbiology product fails to impressmsn.com - September 28 at 11:53 PMIn Iceland election, political stability again at stakenews.yahoo.com - September 26 at 12:55 AMThe 20% return this week takes Actinogen Medical's (ASX:ACW) shareholders one-year gains to 371%finance.yahoo.com - September 23 at 6:19 PM Get Actinogen Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ACW and its competitors with MarketBeat's FREE daily newsletter. Email Address The system that called 2023’s top 7 stocks is at it again… (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here! ACW Media Mentions By Week ACW Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACW News Sentiment▼-1.750.44▲Average Medical News Sentiment ACW News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACW Articles This Week▼10▲ACW Articles Average Week Get Actinogen Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ACW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Artelo Biosciences News Today Ascletis Pharma News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:ACW) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyPrepare for a recession unlike any otherAmerican Hartford Gold GroupRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Actinogen Medical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
